BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3830071)

  • 1. Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
    Konishi J; Iida Y; Kasagi K; Misaki T; Arai K; Endo K; Amemiya T; Abe M; Torizuka K
    Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
    Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
    Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.
    Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R
    Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
    Petersen IA; Kriss JP; McDougall IR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
    Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
    Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy.
    Teng CS; Crombie AL; Hall R; Ross WM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
    De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy in the management of Graves' ophthalmopathy.
    Sakata K; Hareyama M; Oouchi A; Shidou M; Nagakura H; Morita K; Osanai H; Ohtsuka K; Hinoda Y
    Jpn J Clin Oncol; 1998 Jun; 28(6):364-7. PubMed ID: 9730150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant euthyroid Graves' ophthalmopathy and isolated ocular myasthenia gravis.
    Raef H; Ladinsky M; Arem R
    Postgrad Med J; 1990 Oct; 66(780):849-52. PubMed ID: 2099429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results.
    Olivotto IA; Ludgate CM; Allen LH; Rootman J
    Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2085-90. PubMed ID: 3840786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy.
    Tagami T; Tanaka K; Sugawa H; Nakamura H; Miyoshi Y; Mori T; Nakao K
    Endocr J; 1996 Dec; 43(6):689-99. PubMed ID: 9075609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
    Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of Graves' ophthalmopathy.
    Wiersinga WM; Smit T; van der Gaag R; Mourits M; Koornneef L
    Ophthalmic Res; 1989; 21(2):73-82. PubMed ID: 2786616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
    Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
    Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.